Market Research Logo

Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2026

Parenteral Packaging Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2026

In this report, Future Market Insights (FMI) offers a 10-year forecast of the global parenteral packaging market between 2016 and 2026. In terms of value, the market is expected to expand at a CAGR of 10.2% over the forecast period. The current study reveals the market trends and market dynamics in all seven regions that are expected to positively affect the current market environment and future scenario of the parenteral packaging market over the forecast period.

Report Description

This Future Market Insights report inspects the parenteral packaging market for the period 2016–2026. The prime objective of this report is to offer insights into developments in the Parenteral Packaging market that are gradually helping transform global businesses associated with the same.

The global parenteral packaging market report begins by the executive summary and defining various categories and their usage in parenteral packaging. It is followed by market dynamics overview of the global parenteral packaging market, which includes FMI analysis of market trends, drivers, restraints and opportunities that are affecting growth of the parenteral packaging market. It also covers a section summary with rationale for demand of pharmaceuticals packaging with value propositions in segment outlook. Furthermore, to understand the popularity of the market segment and regions, the attractiveness index with elaborated insights on the same is provided, which will show the market’s attractiveness based on the factors such as CAGR and incremental opportunity.

The prime factors powering the demand for parenteral packaging are expansion of global pharmaceuticals industry, ageing population, shifting trend towards plastic & polymer from glass and increasing prevalence of chronic non-communicable diseases. Increase in economic standards and disposable income of individuals across the globe are positively favouring growth of the parenteral packaging market. Factors such as increasing demand for complementary and alternative medicines and high risk of glass breakage could slow down the demand for parenteral packaging in the near future.

Prefilled syringes and multi-compartment bags are recent advancements in the product type segment of parenteral packaging. Among all the product type segments, prefilled segment is expected to grow with the highest CAGR followed by ready-to-mix segment. Based on product type, the market is categorised into bags, ampoules, vials, prefilled syringes and ready-to-mix systems.

The market has also been segmented based on types of material used in packaging of parenteral products, such as glass and plastic & polymer. The plastic & polymer segment is further classified into PVC and polyolefin. According to the analyses, the plastic & polymer segment is expected to exhibit a comprehensive and rapid growth, and acquire high attractiveness in the parenteral packaging market over the forecast period. Under plastic & polymer segment, the synthetic polyolefin plastic & polymer sub-segment is the most dominating segment in terms of value, and is expected to expand at the highest CAGR over the forecast period. Further, on the basis of packaging type segment, the small volume parenteral segment is anticipated to dominate the parenteral packaging market in terms of value, and is expected to remain the most attractive segment over the forecast period in terms of value.

The next section of the report highlights the parenteral packaging adoption, by region, and provides the market outlook for 2016–2026. The study investigates the regional trends contributing to growth of the parenteral packaging market and the market attractiveness regionally, as well as analyses the limit to which the drivers are influencing the parenteral packaging market in each region. Main regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

The above sections, by product type, by material, by packaging type and region, evaluate the present scenario and growth prospects of the parenteral packaging market for 2016–2026. Increased focus of pharmaceuticals producers towards biologics and protein-based product manufacturing ensued demand for pre-filled syringes at an impressive rate. Consequently, it also led to the increased demand for packaging. Parenteral packaging for pre-filled syringes market is presenting lucrative opportunities for pharmaceuticals packaging companies. In 2016, the segment is estimated to account for 31.2% value share in the North America parenteral packaging market; and a gain of 5% is anticipated by the end of the forecast period.

To ascertain the parenteral packaging market size, we have also taken into account the revenue generated by the various manufacturers. The forecast presented here assesses the total revenue generated by value, across the parenteral packaging market. In order to provide an accurate forecast, we initiated by sizing up the current market, which forms the basis on how the parenteral packaging market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis; based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market based on key parameters, such as year-on-year (Y-o-Y) growth rates, to understand the predictability of the parenteral packaging market and identify the right opportunities across the market.

The parenteral packaging segments, by product type, material type, packaging type and region, have been analysed in terms of basis point share (BPS) to understand the individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the parenteral packaging market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is overlooked while forecasting the market. However, absolute dollar opportunity is critical for evaluating the scope of opportunity that a provider can look to achieve, as well as to identify potential resources from a delivery perspective of the Parenteral Packaging market. The overall absolute dollar opportunity along with the segmental split is mentioned in the report.

To understand key growth segments in terms of growth and adoption for parenteral packaging globally, Future Market Insights developed the parenteral packaging market ‘Attractiveness Index.’ The resulting index should help providers identify real market opportunities.

In the final section of the report on parenteral packaging, the ‘dashboard view’ of the companies is provided to compare the current industrial scenario and their contribution in total parenteral packaging market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the parenteral packaging marketplace.

Detailed profiles of parenteral packaging companies are also included in the report to evaluate their long– and short–term strategies, key product offerings and recent developments in the parenteral packaging market. Key market competitors covered in the report include Schott AG, Gerresheimer AG, Becton, Dickinson and Company, Unilife Corporation, Inc., West Pharmaceutical Services, Inc., Ypsomed Holding AG, SiO2 Medical Products, Terumo Corporation, Nipro Corporation and Ompi, Stevanato Group.

Key Segments Covered

Product Type<
Bags
Ampoules
Vials
Prefilled syringes & Cartridges
Ready-to-mix Systems
By Material
Glass
Plastic & Polymer
PVC
Polyolefin

By Packaging Type
Small Volume Parenteral
Large Volume Parenteral

Key Regions/Countries Covered

North America
U.S.
Canada
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Western Europe
Germany
Italy
France
U.K.
Spain
Rest of Western Europe
Eastern Europe
Russia
Rest of Eastern Europe
Asia Pacific Excluding Japan (APEJ)
China
ASEAN
Australia
Rest of APEJ
Japan
Middle East & Africa
GCC
South Africa
Rest of MEA

Key Companies

Schott AG
Gerresheimer AG
Becton, Dickinson and Company
Unilife Corporation, Inc.
West Pharmaceutical Services, Inc.
Ypsomed Holding AG
SiO2 Medical Products
Terumo Corporation
Nipro Corporation
Ompi, Stevanato Group


1.Assumptions and Acronyms Used
2.Research Methodology
3.Executive Summary
4.Parenteral Packaging Market Overview
4.1.Introduction
4.1.1.Parenteral Packaging Market Definition
4.1.2.Parenteral Packaging Market Taxonomy
4.2.Parenteral Packaging Market Overview
4.3.Parent Market Overview
4.4.Parenteral Packaging Market Dynamics
4.4.1.Drivers
4.4.2.Restraints
4.4.3.Trends
4.4.4.Opportunity
4.5.Global Parenteral Packaging Market Forecast, 2016-2026
4.5.1.Market Value Forecast
4.5.1.1.Y-o-Y Growth Projection
4.5.1.2.Absolute $ Opportunity
4.6.Global Parenteral Packaging Market Trends
4.7.Global Parenteral Packaging Market Snapshot (2015)
4.7.1.Market Share, By Product Type
4.7.2.Market Share, By Material Type
4.7.3.Market Share, By End User Type
4.7.4.Market Share, By Region
5.Global Parenteral Packaging Market Analysis, By Product Type
5.1.Introduction
5.1.1.Y-O-Y Growth Comparison, By Product Type
5.1.2.Market Share & Basis Point Share(BPS) Analysis, By Product Type
5.2.Market Forecast, By Product Type
5.2.1.Bags
5.2.1.1.Absolute $ Opportunity
5.2.1.2.Market Value Forecast
5.2.2.Ampoules
5.2.2.1.Absolute $ Opportunity
5.2.2.2.Market Value Forecast
5.2.3.Vials
5.2.3.1.Absolute $ Opportunity
5.2.3.2.Market Value Forecast
5.2.4.Prefilled Syringes and Cartridges
5.2.4.1.Absolute $ Opportunity
5.2.4.2.Market Value Forecast
5.2.5.Ready-to-mix Systems
5.2.5.1.Absolute $ Opportunity
5.2.5.2.Market Value Forecast
5.3.Global Parenteral Packaging Market Attractiveness By Material
5.4.Parenteral Packaging Market Prominent Trends, By Material Type
6.Global Parenteral Packaging Market Analysis, By Material
6.1.Introduction
6.1.1.Y-O-Y Growth Comparison, By Material
6.1.2.Market Share & Basis Point Share(BPS) Analysis, By Material
6.2.Market Forecast, By Material
6.2.1.Glass
6.2.1.1.Absolute $ Opportunity
6.2.1.2.Market Value Forecast
6.2.2.Plastic and Polymer
6.2.2.1.PVC
6.2.2.1.1.Absolute $ Opportunity
6.2.2.1.2.Market Value Forecast
6.2.2.2.Polyolefin
6.2.2.2.1.Absolute $ Opportunity
6.2.2.2.2.Market Value Forecast
6.2.2.2.3.
6.3.Market Attractiveness Analysis, By Material
6.4.Global Parenteral Packaging Market Trends, by Material
7.Global Parenteral Packaging Market Analysis, By Packaging Type
7.1.Introduction
7.1.1.Y-O-Y Growth Comparison, By Packaging Type
7.1.2.Market Share & Basis Point Share(BPS) Analysis, By Packaging Type
7.2.Market Forecast, By Packaging Type
7.2.1.Small Volume Parenteral(SVP)
7.2.1.1.Absolute $ Opportunity
7.2.1.2.Market Value Forecast
7.2.2.Large Volume Parenteral(LVP)
7.2.2.1.Absolute $ Opportunity
7.2.2.2.Market Value Forecast
7.3.Market Attractiveness Analysis, By Packaging Type
7.4.Global Parenteral Packaging Market Trends, by Material
8.Global Parenteral Packaging Market Analysis, By Region
8.1.Introduction
8.1.1.Y-O-Y Growth Projections, by Region
8.1.2.Market share and Basis Point (BPS) Analysis, By Region
8.2.Market Forecast, By Region
8.2.1.North America Market Value Forecast
8.2.2.Latin America Market Value Forecast
8.2.3.Western Europe Market Value Forecast
8.2.4.Eastern Europe Market Value Forecast
8.2.5.APEJ Market Value Forecast
8.2.6.Japan Market Value Forecast
8.2.7.MEA Market Value Forecast
8.3.Regional Attractiveness Analysis
9.North America Parenteral Packaging Market Analysis
9.1.Introduction
9.1.1.Y-O-Y Growth Projections, by Region
9.1.2.Market share and Basis Point (BPS) Analysis, By Region
9.1.3.Key Regulations
9.1.4.Key Trends
9.2.North America Market Value Forecast
9.2.1.Market Value Forecast, By Country
9.2.1.1.U.S. Absolute $ Opportunity
9.2.1.2.Canada Absolute $ Opportunity
9.3.North America Market Value Forecast, By Product Type
9.3.1.Bags
9.3.2.Ampoules
9.3.3.Vials
9.3.4.Prefilled Syringes and Cartridges
9.3.5.Ready-to-mix Systems
9.4.North America Market Value Forecast, By Material
9.4.1.Glass
9.4.2.Plastic and Polymer
9.4.2.1.PVC
9.4.2.2.Polyolefin
9.5.North America Market Value Forecast, By Packaging Type
9.5.1.Small-Volume Parenteral (SVP)
9.5.2.Large Volume Parenteral (LVP)
9.6.North America Parenteral Packaging Market Attractiveness
9.6.1.1.By Country
9.6.1.2.By Product Type
9.6.1.3.By Material
9.6.1.4.By Packaging Type
9.7.Drivers and Restraints Impact Analysis
10.Latin America Parenteral Packaging Market Analysis
10.1.Introduction
10.1.1.Y-O-Y Growth Projections, by Region
10.1.2.Market share and Basis Point (BPS) Analysis, By Region
10.1.3.Key Regulations
10.1.4.Key Trends
10.2.Latin America Market Value Forecast
10.2.1.Market Value Forecast, By Country
10.2.1.1.Argentina Absolute $ Opportunity
10.2.1.2.Brazil Absolute $ Opportunity
10.2.1.3.Mexico Absolute $ Opportunity
10.2.1.4.Rest of Latin America Absolute $ Opportunity
10.3.Latin America Market Value Forecast, By Product Type
10.3.1.Bags
10.3.2.Ampoules
10.3.3.Vials
10.3.4.Prefilled Syringes and Cartridges
10.3.5.Ready-to-mix Systems
10.4.Latin America Market Value Forecast, By Material
10.4.1.Glass
10.4.2.Plastic and Polymer
10.4.2.1.PVC
10.4.2.2.Polyolefin
10.5.Latin America Market Value Forecast, By Packaging Type
10.5.1.Small-Volume Parenteral (SVP)
10.5.2.Large Volume Parenteral (LVP)
10.6.Latin America Parenteral Packaging Market Attractiveness
10.6.1.1.By Country
10.6.1.2.By Product Type
10.6.1.3.By Material
10.6.1.4.By Packaging Type
10.7.Drivers and Restraints Impact Analysis
11.Western Europe Parenteral Packaging Market Analysis
11.1.Introduction
11.1.1.Y-O-Y Growth Projections, by Region
11.1.2.Market share and Basis Point (BPS) Analysis, By Region
11.1.3.Key Regulations
11.1.4.Key Trends
11.2.Western Europe Market Value Forecast
11.2.1.Market Value Forecast, By Country
11.2.1.1.Germany Absolute $ Opportunity
11.2.1.2.Italy Absolute $ Opportunity
11.2.1.3.France Absolute $ Opportunity
11.2.1.4.United Kingdom Absolute $ Opportunity
11.2.1.5.Spain Absolute $ Opportunity
11.2.1.6.Rest of Europe Absolute $ Opportunity
11.3.Western Europe Market Value Forecast, By Product Type
11.3.1.Bags
11.3.2.Ampoules
11.3.3.Vials
11.3.4.Prefilled Syringes and Cartridges
11.3.5.Ready-to-mix Systems
11.4.Western Europe Market Value Forecast, By Material
11.4.1.Glass
11.4.2.Plastic and Polymer
11.4.2.1.PVC
11.4.2.2.Polyolefin
11.5.Western Europe Market Value Forecast, By Packaging Type
11.5.1.Small-Volume Parenteral (SVP)
11.5.2.Large Volume Parenteral (LVP)
11.6.Western Europe Parenteral Packaging Market Attractiveness
11.6.1.1.By Country
11.6.1.2.By Product Type
11.6.1.3.By Material
11.6.1.4.By Packaging Type
11.7.Drivers and Restraints Impact Analysis
12.Eastern Europe Parenteral Packaging Market Analysis
12.1.Introduction
12.1.1.Y-O-Y Growth Projections, by Region
12.1.2.Market share and Basis Point (BPS) Analysis, By Region
12.1.3.Key Regulations
12.1.4.Key Trends
12.2.Eastern Europe Market Value Forecast
12.2.1.Market Value Forecast, By Country
12.2.1.1.Russia Absolute $ Opportunity
12.2.1.2.Rest of Eastern Europe Absolute $ Opportunity
12.3.Eastern Europe Market Value Forecast, By Product Type
12.3.1.Bags
12.3.2.Ampoules
12.3.3.Vials
12.3.4.Prefilled Syringes and Cartridges
12.3.5.Ready-to-mix Systems
12.4.Eastern Europe Market Value Forecast, By Material
12.4.1.Glass
12.4.2.Plastic and Polymer
12.4.2.1.PVC
12.4.2.2.Polyolefin
12.5.Eastern Europe Market Value Forecast, By Packaging Type
12.5.1.Small-Volume Parenteral (SVP)
12.5.2.Large Volume Parenteral (LVP)
12.6.Eastern Europe Parenteral Packaging Market Attractiveness
12.6.1.1.By Country
12.6.1.2.By Product Type
12.6.1.3.By Material
12.6.1.4.By Packaging Type
12.7.Drivers and Restraints Impact Analysis
13.APEJ Parenteral Packaging Market Analysis
13.1.Introduction
13.1.1.Y-O-Y Growth Projections, by Region
13.1.2.Market share and Basis Point (BPS) Analysis, By Region
13.1.3.Key Regulations
13.1.4.Key Trends
13.2.APEJ Market Value Forecast
13.2.1.Market Value Forecast, By Country
13.2.1.1.Greater China Absolute $ Opportunity
13.2.1.2.India Absolute $ Opportunity
13.2.1.3.ASEAN Absolute $ Opportunity
13.2.1.4.Australia Absolute $ Opportunity
13.2.1.5.Rest of APEJ Absolute $ Opportunity
13.3.APEJ Market Value Forecast, By Product Type
13.3.1.Bags
13.3.2.Ampoules
13.3.3.Vials
13.3.4.Prefilled Syringes and Cartridges
13.3.5.Ready-to-mix Systems
13.4.APEJ Market Value Forecast, By Material
13.4.1.Glass
13.4.2.Plastic and Polymer
13.4.2.1.PVC
13.4.2.2.Polyolefin
13.5.APEJ Market Value Forecast, By Packaging Type
13.5.1.Small-Volume Parenteral (SVP)
13.5.2.Large Volume Parenteral (LVP)
13.6.APEJ Parenteral Packaging Market Attractiveness
13.6.1.1.By Country
13.6.1.2.By Product Type
13.6.1.3.By Material
13.6.1.4.By Packaging Type
13.7.Drivers and Restraints Impact Analysis
14.JAPAN Parenteral Packaging Market Analysis
14.1.Introduction
14.1.1.Y-O-Y Growth Projections, by Region
14.1.2.Market share and Basis Point (BPS) Analysis, By Region
14.1.3.Key Regulations
14.1.4.Key Trends
14.2.JAPAN Market Value Forecast
14.3.JAPAN Market Value Forecast, By Product Type
14.3.1.Bags
14.3.2.Ampoules
14.3.3.Vials
14.3.4.Prefilled Syringes and Cartridges
14.3.5.Ready-to-mix Systems
14.4.JAPAN Market Value Forecast, By Material
14.4.1.Glass
14.4.2.Plastic and Polymer
14.4.2.1.PVC
14.4.2.2.Polyolefin
14.5.JAPAN Market Value Forecast, By Packaging Type
14.5.1.Small-Volume Parenteral (SVP)
14.5.2.Large Volume Parenteral (LVP)
14.6.JAPAN Parenteral Packaging Market Attractiveness
14.6.1.1.By Country
14.6.1.2.By Product Type
14.6.1.3.By Material
14.6.1.4.By Packaging Type
14.7.Drivers and Restraints Impact Analysis
15.MEA Parenteral Packaging Market Analysis
15.1.Introduction
15.1.1.Y-O-Y Growth Projections, by Region
15.1.2.Market share and Basis Point (BPS) Analysis, By Region
15.1.3.Key Regulations
15.1.4.Key Trends
15.2.MEA Market Value Forecast
15.2.1.Market Value Forecast, By Country
15.2.1.1.GCC Countries Absolute $ Opportunity
15.2.1.2.South Africa $ Opportunity
15.2.1.3.Rest of MEA Absolute $ Opportunity
15.3.MEA Market Value Forecast, By Product Type
15.3.1.Bags
15.3.2.Ampoules
15.3.3.Vials
15.3.4.Prefilled Syringes and Cartridges
15.3.5.Ready-to-mix Systems
15.4.MEA Market Value Forecast, By Material
15.4.1.Glass
15.4.2.Plastic and Polymer
15.4.2.1.PVC
15.4.2.2.Polyolefin
15.5.MEA Market Value Forecast, By Packaging Type
15.5.1.Small-Volume Parenteral (SVP)
15.5.2.Large Volume Parenteral (LVP)
15.6.MEA Parenteral Packaging Market Attractiveness
15.6.1.1.By Country
15.6.1.2.By Product Type
15.6.1.3.By Material
15.6.1.4.By Packaging Type
15.7.Drivers and Restraints Impact Analysis
16.Competition Landscape
16.1.Competitive Dashboard
16.2.Company Profile
16.2.1.Revenue
16.2.2.Product Types/Brand Offerings
16.2.3.Key Developments
16.2.4.SWOT Analysis
16.3.Companies Profiled
16.3.1.SCHOTT AG
16.3.2.Gerresheimer AG
16.3.3.Becton, Dickinson and Company
16.3.4.Unilife Corporation
16.3.5.West Pharmaceutical Services, Inc.
16.3.6.Ypsomed Holding AG
16.3.7.SiO2 Medical Products
16.3.8.Terumo Corporation
16.3.9.Nipro Corporation
16.3.10.Ompi, Stevanato Group

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report